Skip to main content
Signal8

Schwab Andrew J.

SEC insider (Form 3/4/5 filer). CIK 0001598549. Director & 10% Owner at Skye Bioscience, Inc. (SKYE) and 1 other issuer. 42 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SAN FRANCISCO, CA.

Companies Schwab Andrew J. has filed insider reports for

  • Skye Bioscience, Inc. (SKYE): Director, 10% Owner
  • Camp4 Therapeutics Corp (CAMP): Director
Schwab Andrew J. profile photo

Schwab Andrew J.

CIK: 0001598549

Transaction Breakdown

Open Market Buys (P)1 (2.4%)

High conviction signal

Open Market Sales (S)30 (71.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (19.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (7.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Skye Bioscience, Inc. logo
SKYE

Skye Bioscience, Inc.

Director10% Owner
Camp4 Therapeutics Corp logo
CAMP

Camp4 Therapeutics Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (42 total)

  • Skye Bioscience, Inc. logo
    SKYE

    Skye Bioscience, Inc.

    Sep 23, 2026
    Sale
    Indirect
    4.5K shares at avg. $1.61$7K
  • Skye Bioscience, Inc. logo
    SKYE

    Skye Bioscience, Inc.

    Sep 23, 2026
    Sale
    Indirect
    114.9K shares at avg. $1.61$185K
  • Skye Bioscience, Inc. logo
    SKYE

    Skye Bioscience, Inc.

    Sep 22, 2026
    Sale
    Indirect
    27.6K shares at avg. $1.65$46K
  • Skye Bioscience, Inc. logo
    SKYE

    Skye Bioscience, Inc.

    Sep 22, 2026
    Sale
    Indirect
    1.1K shares at avg. $1.65$2K
  • Skye Bioscience, Inc. logo
    SKYE

    Skye Bioscience, Inc.

    Sep 16, 2026
    Sale
    Indirect
    32.6K shares at avg. $1.91$62K
  • Skye Bioscience, Inc. logo
    SKYE

    Skye Bioscience, Inc.

    Sep 16, 2026
    Sale
    Indirect
    1.3K shares at avg. $1.91$2K
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Aug 27, 2026
    Sale
    Indirect
    400K shares at avg. $4.04$1.6M
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Aug 24, 2026
    Sale
    Indirect
    10 shares at avg. $4.50$45
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Aug 21, 2026
    Sale
    Indirect
    32K shares at avg. $4.50$144K
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Aug 20, 2026
    Sale
    Indirect
    114.7K shares at avg. $4.54$521K

1-10 of 42